• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽对人胰腺癌细胞系Capan-1的调控

VIP regulation of a human pancreatic cancer cell line: Capan-1.

作者信息

Ruellan C, Scemama J L, Clerc P, Fagot-Revurat P, Clemente F, Ribet A

出版信息

Peptides. 1986;7 Suppl 1:267-71. doi: 10.1016/0196-9781(86)90200-7.

DOI:10.1016/0196-9781(86)90200-7
PMID:3018700
Abstract

VIP and secretin control the secretory function of the normal pancreas. We analysed their regulatory functions in a human pancreatic cancer cell line: Capan-1. Saturation binding experiments with 125I-VIP showed the existence of one class of binding sites of very high affinity: KD 6.4 +/- 3.0 X 10(-11) M and a low Bmax: 12 fmoles/10(6) cells, in both intact cells and membrane preparations. This site has not yet been described in normal or tumorous digestive cells. Competition binding experiments let us characterize two more binding sites, KD: 2.1 +/- 0.7 X 10(-9) M and 5.0 +/- 0.6 X 10(-8) M and the corresponding Bmax: 120 and 500 fmoles/10(6) cells. These sites are similar to those found on cells of the digestive tract. Competition binding experiments gave the following IC50: 3.0 +/- 0.9 X 10(-9) M for VIP; 2 +/- 0.6 X 10(-6) M for PHI; and 1 +/- 0.7 X 10(-5) M for secretin. VIP elicited a cAMP rise, the half maximal response being obtained at 1.2 X 10(-10) M. Secretin induced a cAMP response but only for concentrations higher than 10(-8) M. VIP receptors were found to be modulated by two factors: cell ageing and cell density. Cells chronically treated with VIP showed a slight decrease of their proliferation; insulin exerted an opposite effect. It is concluded that at the difference of normal pancreatic cells, the present cell line lacks secretin-preferring receptors and acquires some of the properties of intestinal cells.

摘要

血管活性肠肽(VIP)和促胰液素控制着正常胰腺的分泌功能。我们分析了它们在人胰腺癌细胞系Capan-1中的调节功能。用125I-VIP进行的饱和结合实验表明,在完整细胞和膜制剂中均存在一类高亲和力的结合位点:解离常数(KD)为6.4±3.0×10⁻¹¹ M,最大结合容量(Bmax)较低,为12 fmol/10⁶个细胞。这种位点在正常或肿瘤性消化细胞中尚未见报道。竞争结合实验使我们鉴定出另外两个结合位点,KD分别为2.1±0.7×10⁻⁹ M和5.0±0.6×10⁻⁸ M,相应的Bmax分别为120和500 fmol/10⁶个细胞。这些位点与在消化道细胞中发现的位点相似。竞争结合实验得出以下半数抑制浓度(IC50):VIP为3.0±0.9×10⁻⁹ M;胰高血糖素样肽(PHI)为2±0.6×10⁻⁶ M;促胰液素为1±0.7×10⁻⁵ M。VIP引起细胞内环磷酸腺苷(cAMP)升高,在1.2×10⁻¹⁰ M时达到半数最大反应。促胰液素诱导cAMP反应,但仅在浓度高于10⁻⁸ M时出现。发现VIP受体受两个因素调节:细胞老化和细胞密度。长期用VIP处理的细胞其增殖略有下降;胰岛素则发挥相反的作用。结论是,与正常胰腺细胞不同,该细胞系缺乏促胰液素偏好性受体,并获得了一些肠细胞的特性。

相似文献

1
VIP regulation of a human pancreatic cancer cell line: Capan-1.血管活性肠肽对人胰腺癌细胞系Capan-1的调控
Peptides. 1986;7 Suppl 1:267-71. doi: 10.1016/0196-9781(86)90200-7.
2
Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.火鸡大脑皮层中血管活性肠肽和垂体腺苷酸环化酶激活多肽的受体:通过[125I]-血管活性肠肽结合进行表征及其对环磷酸腺苷合成的影响
Gen Comp Endocrinol. 2004 Jun;137(2):187-95. doi: 10.1016/j.ygcen.2004.03.007.
3
[D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.[D-苯丙氨酸4]肽组氨酸异亮氨酰胺([D-苯丙氨酸4]PHI),一种高度选择性的血管活性肠肽(VIP)激动剂,可区分大鼠胰腺膜中偏好VIP的受体和偏好促胰液素的受体。
Eur J Biochem. 1987 Jun 1;165(2):243-9. doi: 10.1111/j.1432-1033.1987.tb11434.x.
4
Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation.人胰腺腺癌细胞系中血管活性肠肽(VIP)受体的存在。细胞增殖过程中cAMP反应的调节。
Biochem Biophys Res Commun. 1983 Mar 29;111(3):958-63. doi: 10.1016/0006-291x(83)91393-1.
5
Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini.豚鼠胰腺腺泡上的血管活性肠肽和促胰液素受体。
Peptides. 1987 Jul-Aug;8(4):633-7. doi: 10.1016/0196-9781(87)90037-4.
6
Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
Regul Pept. 1993 Sep 22;47(3):223-32. doi: 10.1016/0167-0115(93)90389-p.
7
Actions of a newly isolated intestinal peptide PHI on pancreatic acini.一种新分离的肠道肽PHI对胰腺腺泡的作用。
Am J Physiol. 1981 Dec;241(6):G498-502. doi: 10.1152/ajpgi.1981.241.6.G498.
8
Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.血管活性肠肽、胰高血糖素样肽和促胰液素的心脏受体能够激活腺苷酸环化酶并介导变力性和变时性效应。物种差异与病理生理学。
Peptides. 1984 Mar-Apr;5(2):341-53. doi: 10.1016/0196-9781(84)90232-8.
9
Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.人结肠腺癌细胞系HT-29中血管活性肠肽(VIP)受体的分子鉴定及结构要求
Biochem J. 1985 Oct 1;231(1):139-43. doi: 10.1042/bj2310139.
10
Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.血管活性肠肽(VIP)刺激携带VIP-1受体的人胰腺腺癌衍生细胞的体外生长。
Cancer Res. 1997 Apr 15;57(8):1475-80.

引用本文的文献

1
Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.胃肠激素作为外分泌性胰腺腺癌的潜在辅助治疗手段
Int J Pancreatol. 1998 Dec;24(3):169-80. doi: 10.1007/BF02788419.
2
Adenylate cyclase activity in human pancreatic adenocarcinoma cell lines.人胰腺腺癌细胞系中的腺苷酸环化酶活性
Int J Pancreatol. 1996 Feb;19(1):39-47. doi: 10.1007/BF02788374.
3
Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1).血管活性肠肽对培养的人胰腺癌细胞(Capan-1)中黏蛋白分泌调节的影响。
In Vitro Cell Dev Biol Anim. 1995 Mar;31(3):227-33. doi: 10.1007/BF02639438.
4
Phosphorylation-regulated low-conductance Cl- channels in a human pancreatic duct cell line.人胰腺导管细胞系中磷酸化调节的低电导氯离子通道
Pflugers Arch. 1993 Oct;425(1-2):1-8. doi: 10.1007/BF00374496.
5
Cyclic-AMP-stimulated synthesis and release of carcinoembryonic antigen by pancreatic cancer cells.环磷酸腺苷刺激胰腺癌细胞合成并释放癌胚抗原。
Int J Pancreatol. 1988 Mar;3(2-3):171-84. doi: 10.1007/BF02798929.
6
Two subclasses of EGF receptors in the human pancreatic cancer cell lines CAPAN-1 and MIA PaCa-2.人胰腺癌细胞系CAPAN-1和MIA PaCa-2中表皮生长因子受体的两个亚类。
Int J Pancreatol. 1990 Mar;6(2):119-28. doi: 10.1007/BF02933046.
7
Anion channels in a human pancreatic cancer cell line (Capan-1) of ductal origin.源于导管的人胰腺癌细胞系(Capan-1)中的阴离子通道。
Pflugers Arch. 1992 Jan;420(1):46-53. doi: 10.1007/BF00378640.